On 14^th August 2024, the World Health Organization declared outbreaks of mpox in Africa to be a Public Health Emergency of International Concern.

What is mpox?

Mpox is a viral infection that was previously known as “monkeypox”.

It shares some similarities with smallpox, to the extent that smallpox vaccine may be cross-protective; however, the illness is much less severe. (Waning population immunity to smallpox, since vaccination programmes ended in 1980, is one possible reason for the increased tendency to outbreaks now.)

So far, there have been 14,000 cases reported in Africa, with 524 deaths. Sweden has just reported the first case of clade I mpox outside Africa in the current outbreak (see below).

Previously confined to central Africa, recent outbreaks have ultimately spread globally, which is why the WHO has now decided to urge a concerted global response.

How is it spread?

The infection is spread mainly by close direct / intimate contact with body fluids and secretions, and by sexual exposure.

It can also be spread by contact with animals, or their droppings, or by eating under-cooked contaminated meat – so-called “bush meat”. The animal reservoir of infection is mainly among rodents and non-human primates.

The illness

Infection may be symptomless, but in most cases, symptoms appear 7 to 14 days following exposure.

Mpox is characterised by blistering skin lesions that are often extremely painful (and highly infective to other people), occurring particularly on the skin, genitals and face. They can be sparse, or even single blisters.

Other symptoms include fever, chills, headache, muscle aches, fatigue and swollen lymph glands.

The blisters may appear first on the face, spreading to other parts of the body; or alternatively in the genital area if the infection was acquired by sexual contact. Extensive lesions around the mouth may make eating and drinking painful or impossible, requiring intravenous treatment.

The illness is considerably more serious in people with HIV infection or reduced immunity. Severity of infection is also linked to the degree of exposure.

Mpox strains

There are two strains (called clades – Clade I and Clade II) that differ in severity and ease of spread.

Clade II tends to be more severe (up to 1,000 times more virulent than clade II) and occurs in Central Africa, Clade II occurs mainly in West Africa and may sometimes be more easily transmissible. Mutations into sub-strains is also occurring, which makes testing more complicated, especially in countries where resources are poor.

Where are cases occurring?

It is important to bear in mind that official statistics generally underestimate true numbers of cases, since not everyone with symptoms seeks medical attention, and not all cases undergo full testing.

Laboratory-confirmed cases have been reported in:

• Burundi: over 100 cases (Clade Ib) throughout the country
• Central African Republic: 28 cases (Clade I) throughout the country
• Côte d’Ivoire: 6 cases (Clade II) in Abidjan and Bas-Sassandra districts
• Democratic Republic of the Congo: > 14,000 cases (Clades Ia and Ib) throughout the country, mainly in Équateur, Sankuru, South Kivu, and Sud Ubangi provinces
• Kenya: 1 case (Clade Ib) in Taita-Taveta County
• Republic of the Congo: > 120 cases (Clade I) throughout most of the country, mainly in Cuvette, Kouilou, Likouala, and Point-Noire departments
• Rwanda: 4 cases (Clade Ib); no specified locations
• South Africa: 24 cases (Clade IIb) in Gauteng (12 cases and 2 deaths), KwaZulu-Natal (11 cases and 1 death), and Western Cape (1 case) provinces
• Uganda: 2 cases (Clade Ib) in Kasese District; no secondary transmission has been reported

A previous outbreak in 2022 resulted in spread to over 40 countries – with over 30,000 cases in the USA, for example, mainly in the MSM community.

Are visitors at risk?

Although current news reports of mpox cases are alarming and intended to generate a global public health response, so as to raise awareness and help bring outbreaks under control, most tourists and travellers to Africa are not at risk.

Travel to Africa for the usual tourist activities (e.g. safari, outdoor activities, beach) should be unaffected by the outbreak.

Older travellers who have previously been vaccinated against smallpox may still have some additional cross-protection against mpox.

• Risk arises from close contact (especially sexual contact) with infected people.
• Those at highest risk are men who have sex with men (MSM).
• High-risk behaviour is easily avoided, and safe-sex precautions reduce the risk of infection.
• Risk also arises from close physical contact with infected animals, or by eating under-cooked bush meat – which should be avoided. (Thorough cooking kills the virus.)
• Healthcare workers may be at risk if caring for people who are ill with mpox
• Journalists and news media personnel should avoid physical contact, keep their distance and observe the usual hygiene precautions when reporting on the evolving mpox outbreak situation

Mpox vaccines and treatment

• In the UK, vaccination is available for MSM and healthcare workers via the NHS.
• Current vaccines protect against all strains.
• Vaccination within 14 days of possible exposure also appears to confer protection (post-exposure protection).
• Several antiviral drugs can provide benefit in the most severe cases.

More information:

UK: NaTHNaC 

USA: CDC 

With monkeypox cases being recorded in over 20 countries across the globe, people are becoming increasingly concerned about its spread and transmission.

Following 2 years of the Covid-19 pandemic, this outbreak has reignited the public’s fear and uncertainty of infectious diseases. 

Whilst the media coverage of the monkeypox outbreak is alarming, we would like to reassure our patients that as it stands, the risk is still very minimal and vaccination is not advised as a precautionary measure. Whilst vaccines will undoubtedly be a key part of containing the outbreak, for now, only people who may have been exposed are being offered vaccination.

Our Medical Director & Travel Medicine Specialist, Dr Richard Dawood explains;

“Lots of people have been getting in touch with us to ask about a monkeypox vaccination, but this is not available privately. It is currently only being offered to anyone identified as a direct, close contact of a confirmed case deemed to be at sufficient risk.

The current outbreak does, however, highlight the need to think about your vaccine protection more generally, whether for travel or simply to protect your health and well-being, taking advantage of the best vaccines currently available.”

In a more general sense, it is never too late to catch up on childhood vaccinations, incomplete vaccination courses or any required boosters.

Your immune system naturally decreases with age and certain diseases are also more prevalent in older adults so there may be new vaccinations which are now suitable for you to consider for preventable diseases. Some health conditions can also weaken the body’s immune response, making you more vulnerable to infectious diseases, complications and hospitalisation. Therefore, it is important to ask your GP which vaccinations would be suitable for keeping you healthy.
 – For more information on wellness vaccinations.

If you are travelling soon and haven’t had a travel consultation with a travel nurse, perhaps it is time to consider one. Travel nurses are experts in travel health and will advise which travel vaccinations & medications you should consider based on the risk of where you are travelling to and your itinerary once there.
– For more information on travel consultations.

To conclude, we’d like to dismiss a couple of dangerous myths about monkeypox that are unnecessarily scaremongering the public:

Myth 1: Monkeypox is as contagious as COVID-19 or smallpox

Myth 2: Monkeypox is a new virus.

In summary, we, like the rest of the medical field, will be keeping a close eye on the progression of the Monkeypox outbreak and should our advice change based on new information, we will update this statement accordingly.

For more information on Monkeypox.